This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
₹4,462
Share price
0.00%
Change (1 day)
37.76%
Change (1 year)
Categories
Market capitalization of ChemoCentryx (CCXI)
Last known market cap: ₹320.87 Billion
On November 25, 2022 ChemoCentryx had a market cap of ₹320.87 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ChemoCentryx from 2012 to 2022
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2022 | ₹309.41 B | 63.03% |
| 2021 | ₹189.78 B | -39.44% |
| 2020 | ₹313.40 B | 84.48% |
| 2019 | ₹169.88 B | 339.65% |
| 2018 | ₹38.64 B | 108.56% |
| 2017 | ₹18.52 B | -22.93% |
| 2016 | ₹24.03 B | 1.07% |
| 2015 | ₹23.78 B | 26.47% |
| 2014 | ₹18.80 B | 22.59% |
| 2013 | ₹15.34 B | -29.55% |
| 2012 | ₹21.77 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | ₹1.513 T | 371.80% | 🇺🇸 USA |
 | ₹28.127 T | 8,665.88% | 🇺🇸 USA |
 | ₹6.351 T | 1,879.37% | 🇬🇧 UK |
 | ₹9.575 T | 2,884.30% | 🇺🇸 USA |
 | ₹31.170 T | 9,614.21% | 🇺🇸 USA |
 | ₹13.466 T | 4,096.80% | 🇺🇸 USA |
 | ₹11.013 T | 3,332.49% | 🇺🇸 USA |
 | ₹1.508 T | 370.08% | 🇮🇱 Israel |
 | ₹17.586 T | 5,380.93% | 🇺🇸 USA |